The Patent Finder

Neurotech USA, Inc.

Also on record
Records under this name other than the patents Neurotech USA, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Back to Neurotech USA, Inc.

PatentTitleStatus Expires Confidence
US 8,455,470Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,309,315Apparatus, method and computer program product to facilitate ordinary visual perception via an early perceptual-motor extraction of relational information from a light stimuli array to trigger an overall visual-sensory motor integration in a subject
Formerly held
Term ended
Term ended Nov 3, 2025 · From the USPTO record
Term endedTerm ended Nov 3, 2025From the USPTO record
US 8,426,735Stretchable conductor and method for producing the same
Formerly held
Lapsed on the fee record
Ended Apr 23, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 23, 2025From the USPTO record
US 7,371,896Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Formerly held
Term ended
Term ended Aug 1, 2023 · From the USPTO record
Term endedTerm ended Aug 1, 2023From the USPTO record
US 6,927,303Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Formerly held
Term ended
Term ended Jun 19, 2023 · From the USPTO record
Term endedTerm ended Jun 19, 2023From the USPTO record
US 7,189,878Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Formerly held
Term ended
Term ended Jun 19, 2023 · From the USPTO record
Term endedTerm ended Jun 19, 2023From the USPTO record
US 7,319,160Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Formerly held
Term ended
Ended no later than Jun 19, 2023 · From the USPTO record
Term endedEnded no later than Jun 19, 2023From the USPTO record
US 9,031,660Eye implant apparatus and update system for the same
Lapsed on the fee record
Ended May 12, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 12, 2023From the USPTO record
US 7,750,045Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
Formerly held
Term ended
Term ended Apr 9, 2023 · From the USPTO record
Term endedTerm ended Apr 9, 2023From the USPTO record
US 6,644,976Apparatus, method and computer program product to produce or direct movements in synergic timed correlation with physiological activity
Formerly held
Term ended
Term ended Sep 10, 2021 · From the USPTO record
Term endedTerm ended Sep 10, 2021From the USPTO record
10 of 62 patents shown.
Pro members see all 62.
Pro members: see all 62 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited